Achieve Life Sciences Overview
- Year Founded
-
1991
- Status
-
Public
- Employees
-
38
- Stock Symbol
-
QUIT
- Investments
-
2
- Share Price
-
$6.28
- (As of Thursday Closing)
Achieve Life Sciences General Information
Description
Achieve Life Sciences Inc is a late-stage specialty pharmaceutical company focused on the world-wide development and commercialization of cytisinicline as a treatment for nicotine dependence. Its New Drug Application (NDA) for cytisinicline for smoking cessation in adults is supported by two completed Phase 3 studies and an open-label long-term safety study. It has also completed a Phase 2 study of cytisinicline in nicotine e-cigarette cessation, conducted an end-of-Phase 2 meeting with the FDA, and has received Breakthrough Therapy designation for the vaping cessation indication.
Contact Information
Website
www.achievelifesciences.comCorporate Office
- 22722 29th Drive South East
- Suite 100
- Bothell, WA 98021
- United States
Corporate Office
- 22722 29th Drive South East
- Suite 100
- Bothell, WA 98021
- United States
Achieve Life Sciences Timeline
Achieve Life Sciences Stock Performance
As of 12-Nov-2026, Achieve Life Sciences’s stock price is $6.28. Its current market cap is $692M with 110M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $6.28 | $6.45 | $2.62 - $8.64 | $692M | 110M | 1.44M | -$1.43 |
Achieve Life Sciences Financials Summary
As of 30-Sep-2026, Achieve Life Sciences has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 660,126 | 226,417 | 87,987 | 83,612 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (114,402) | (55,096) | (39,774) | (27,559) |
| Net Income | (111,709) | (54,648) | (39,827) | (29,815) |
| Total Assets | 206,423 | 41,790 | 38,633 | 19,371 |
| Total Debt | 14,047 | 14,955 | 9,958 | 16,731 |
Achieve Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Achieve Life Sciences Comparisons
Industry
Financing
Details
Achieve Life Sciences Competitors (4)
One of Achieve Life Sciences’s 4 competitors is Axsome Therapeutics, a Formerly VC-backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Axsome Therapeutics | Formerly VC-backed | New York, NY | ||||
| Roche | Corporation | Basel, Switzerland | ||||
| Pfizer | Corporation | New York, NY | ||||
| 22nd Century Group | Corporation | Mocksville, NC |
Achieve Life Sciences Patents
Achieve Life Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2024400864-A1 | Cytisine formulations | Pending | 12-Dec-2023 | ||
| EP-4823574-A1 | Cytisine formulations | Pending | 12-Dec-2023 | ||
| US-20250186417-A1 | Cytisine formulations | Pending | 12-Dec-2023 | ||
| WO-2025128723-A1 | Cytisine formulations | Inactive | 12-Dec-2023 | ||
| AU-2024398196-A1 | Smoking cessation compounds having reduced nitrosamines and associated methods | Pending | 12-Dec-2023 | A61K31/439 |
Achieve Life Sciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Achieve Life Sciences Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Achieve Life Sciences Acquisitions (2)
Achieve Life Sciences’s most recent deal was a Merger/Acquisition with OncoGenex Pharmaceuticals for . The deal was made on 01-Aug-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| OncoGenex Pharmaceuticals | 01-Aug-2017 | Merger/Acquisition | Drug Discovery | ||
| Extab | 14-May-2015 | Merger/Acquisition | Drug Discovery |
Achieve Life Sciences ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
38.04 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Biotechnology
Subindustry
of 431
Rank
Percentile
Achieve Life Sciences FAQs
-
When was Achieve Life Sciences founded?
Achieve Life Sciences was founded in 1991.
-
Where is Achieve Life Sciences headquartered?
Achieve Life Sciences is headquartered in Bothell, WA.
-
What is the size of Achieve Life Sciences?
Achieve Life Sciences has 38 total employees.
-
What industry is Achieve Life Sciences in?
Achieve Life Sciences’s primary industry is Biotechnology.
-
Is Achieve Life Sciences a private or public company?
Achieve Life Sciences is a Public company.
-
What is Achieve Life Sciences’s stock symbol?
The ticker symbol for Achieve Life Sciences is QUIT.
-
What is the current stock price of Achieve Life Sciences?
As of 12-Nov-2026 the stock price of Achieve Life Sciences is $6.28.
-
What is the current market cap of Achieve Life Sciences?
The current market capitalization of Achieve Life Sciences is $692M.
-
Who are Achieve Life Sciences’s competitors?
Axsome Therapeutics, Roche, Pfizer, and 22nd Century Group are competitors of Achieve Life Sciences.
-
What is Achieve Life Sciences’s annual earnings per share (EPS)?
Achieve Life Sciences’s EPS for 12 months was -$1.43.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
